BOW vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
BOW exhibits a mixed financial profile with a Piotroski F-Score of 4/9 indicating stable but not strong financial health, and no available Altman Z-Score limits distress risk assessment. The company shows robust revenue and earnings growth, solid profitability margins, and a very low debt/equity ratio, yet faces headwinds from negative insider sentiment and weak technical trends. Valuation metrics suggest the stock is trading below analyst target prices but above the conservative Graham Number, implying moderate overvaluation for a defensive investor. Despite strong recent earnings surprises and growth, declining price performance over the past year and significant insider selling raise caution.
JPM shows bullish fundamentals based on deterministic rules. Financial strength is weak (F-Score 2/9). Key strengths include strong valuation and growth metrics. Price trades at a 109.8% premium to fair value estimate ($140.21), limiting near-term upside from a valuation perspective.
Compare Another Pair
Related Comparisons
BOW vs JPM: Head-to-Head Comparison
This page compares Bowhead Specialty Holdings Inc. (BOW) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.